Cargando…
Polymer–Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
[Image: see text] A series of polymer–drug conjugates based on 2-methacryloyloxyethyl phosphorylcholine (MPC) was prepared with the glioblastoma drug temozolomide (TMZ) as pendent groups. Random and block copolymers were synthesized by reversible addition–fragmentation chain-transfer (RAFT) polymeri...
Autores principales: | Ward, Sarah M., Skinner, Matthew, Saha, Banishree, Emrick, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220362/ https://www.ncbi.nlm.nih.gov/pubmed/30354145 http://dx.doi.org/10.1021/acs.molpharmaceut.8b00766 |
Ejemplares similares
-
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020) -
Transferrin-Conjugated
PLGA Nanoparticles for Co-Delivery
of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023) -
Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response
por: Panzarini, Elisa, et al.
Publicado: (2020) -
Ultrasound‐mediated delivery of flexibility‐tunable polymer drug conjugates for treating glioblastoma
por: Sun, Tao, et al.
Publicado: (2022) -
SS-1 Therapeutic challenges for glioblastoma: Temozolomide and its issues?
por: Nagane, Motoo
Publicado: (2020)